Organoids and regenerative hepatology.
Ovid Technologies (Wolters Kluwer Health)
MetadataShow full item record
Jalan-Sakrikar, N., Brevini, T., Huebert, R. C., & Sampaziotis, F. (2023). Organoids and regenerative hepatology.. Hepatology https://doi.org/10.1002/hep.32583
The burden of liver diseases is increasing worldwide, with liver transplantation remaining the only treatment option for end-stage liver disease. Regenerative medicine holds great potential as a therapeutic alternative, aiming to repair or replace damaged liver tissue with healthy functional cells. The properties of the cells used are critical for the efficacy of this approach. The advent of liver organoids has not only offered new insights into human physiology and pathophysiology, but also provided an optimal source of cells for regenerative medicine and translational applications. Here, we discuss various historical aspects of 3D organoid culture, how it has been applied to the hepatobiliary system, and how organoid technology intersects with the emerging global field of liver regenerative medicine. We outline the hepatocyte, cholangiocyte, and nonparenchymal organoids systems available and discuss their advantages and limitations for regenerative medicine as well as future directions.
Humans, Gastroenterology, Organoids, Liver, Regenerative Medicine, Hepatocytes
Medical Research Council (MC_PC_17230)
Embargo Lift Date
External DOI: https://doi.org/10.1002/hep.32583
This record's URL: https://www.repository.cam.ac.uk/handle/1810/338271
All Rights Reserved
Licence URL: http://www.rioxx.net/licenses/all-rights-reserved
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: email@example.com